Literature DB >> 40848

Prostaglandin synthetase activity in acute ulcerative colitis: effects of treatment with sulphasalazine, codeine phosphate and prednisolone.

P R Smith, D J Dawson, C H Swan.   

Abstract

Prostaglandin synthetase activity in rectal biopsy specimens from patients with ulcerative colitis has been shown to fall on treatment with sulphasalazine, local steroids, and codeine phosphate. In vitro studies have shown that sulphasalazine is an inhibitor of prostaglandin synthetase, although less potent than indomethacin, whereas prednisolone and codeine phosphate were inactive. It is suggested that the therapeutic action of sulphasalazine may be related in part to its action in inhibiting prostaglandin biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 40848      PMCID: PMC1412641          DOI: 10.1136/gut.20.9.802

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  24 in total

1.  Hydrocortisone inhibits prostaglandin production by mouse fibrosarcoma cells.

Authors:  A H Tashjian; E F Voelkel; J McDonough; L Levine
Journal:  Nature       Date:  1975-12-25       Impact factor: 49.962

2.  PROSTAGLANDINS AND RELATED FACTORS: XIX. THIN-LAYER CHROMATOGRAPHY OF PROSTAGLANDINS.

Authors:  K GREEN; B SAMUELSSON
Journal:  J Lipid Res       Date:  1964-01       Impact factor: 5.922

3.  Inhibition of release of prostaglandins as an explanation of some of the actions of anti-inflammatory corticosteroids.

Authors:  G P Lewis; P J Piper
Journal:  Nature       Date:  1975-03-27       Impact factor: 49.962

4.  Prostaglandin secretion by medullary carcinoma of the thyroid. A possible cause of the associated idarrhoea.

Authors:  E D Williams; S M Karim; M Sandler
Journal:  Lancet       Date:  1968-01-06       Impact factor: 79.321

5.  Effect of oral prostaglandin E1 on intestinal transit in man.

Authors:  J J Misiewicz; S L Waller; N Kiley
Journal:  Lancet       Date:  1969-03-29       Impact factor: 79.321

6.  Prostaglandins in amine-peptide-secreting tumours.

Authors:  M Sandler; S M Karim; E D Williams
Journal:  Lancet       Date:  1968-11-16       Impact factor: 79.321

7.  Effects of anti-inflammatory drugs on prostaglandin biosynthesis.

Authors:  R Flower; R Gryglewski; K Herbaczyńska-Cedro; J R Vane
Journal:  Nat New Biol       Date:  1972-07-26

8.  Determination of prostaglandin synthetase activity in rectal biopsy material and its significance in colonic disease.

Authors:  D W Harris; P R Smith; C H Swan
Journal:  Gut       Date:  1978-10       Impact factor: 23.059

9.  Release of prostaglandin by mitogen- and antigen-stimulated leukocytes in culture.

Authors:  V A Ferraris; F R DeRubertis
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

10.  The metabolism of salicylazosulphapyridine in ulcerative colitis. I. The relationship between metabolites and the response to treatment in inpatients.

Authors:  K M Das; M A Eastwood; J P McManus; W Sircus
Journal:  Gut       Date:  1973-08       Impact factor: 23.059

View more
  26 in total

Review 1.  Sulfasalazine. Multiplicity of action.

Authors:  T S Gaginella; R E Walsh
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

Review 2.  Phagocytes, toxic oxygen metabolites and inflammatory bowel disease: implications for treatment.

Authors:  J G Williams
Journal:  Ann R Coll Surg Engl       Date:  1990-07       Impact factor: 1.891

Review 3.  Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapy.

Authors:  A B Hawthorne; C J Hawkey
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

Review 4.  Prostaglandins and ulcerative colitis.

Authors:  D S Rampton; C J Hawkey
Journal:  Gut       Date:  1984-12       Impact factor: 23.059

5.  Ulcerative colitis: an overview.

Authors:  A Archambault
Journal:  Can Fam Physician       Date:  1990-02       Impact factor: 3.275

6.  Modulation of human colonic arachidonic acid metabolism by sulfasalazine.

Authors:  C J Hawkey; N K Boughton-Smith; B J Whittle
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

7.  Ulcerative colitis: effect of sulphasalazine, its metabolites and indomethacin on the ability of human colonic mucosa to metabolize prostaglandins in vitro.

Authors:  K Hillier; P J Mason; S Pacheco; C L Smith
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

8.  Do prostaglandins cause gastrointestinal mucosal injury?

Authors:  M G Northway; D O Castell
Journal:  Dig Dis Sci       Date:  1981-05       Impact factor: 3.199

9.  Increased suppressor cell activity in inflammatory bowel disease.

Authors:  G Holdstock; B F Chastenay; E L Krawitt
Journal:  Gut       Date:  1981-12       Impact factor: 23.059

10.  Inhibition of leucocyte motility by drugs used in ulcerative colitis.

Authors:  J M Rhodes; T C Bartholomew; D P Jewell
Journal:  Gut       Date:  1981-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.